Marinus investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of marinus pharmaceuticals, inc. - mrns

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of marinus pharmaceuticals, inc. (nasdaqgm: mrns) to immedica pharma ab. under the terms of the proposed transaction, shareholders of marinus will receive $0.55 in cash for each share of marinus that they own. ksf is seeking to determine whether this consideration and the process that led to it are adequate, or w.
GM Ratings Summary
GM Quant Ranking